Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages

News

News

News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors

Welcome to epgonline.org - the website for healthcare professionals

What's new?

 

Launch of accredited Type 1 Childhood Diabetes CME

A new EACCME-accredited CME activity Individual Patient Management in Type 1 Childhood Diabetes has launched on epgonline.org. Intended for medical professionals involved in the management of young patients with type 1 diabetes, this module consists of six sessions, each covering a different aspect of managing psychosocial issues in type 1 childhood diabetes.

Explore at your own pace and test your knowledge using the interactive learning exercises. The activity is totally free, and on completion you will be awarded 1 European CME credit (ECMEC). 

 

Anti-Infectives Knowledge Network (AIKN) CDI Updates

Recently updated with new reports and policy updates as well as key perspectives on Clostridium difficile infection (CDI), the Anti-Infectives Knowledge Network shares expertise and experience in the area of anti-infectives.

This educational resource is an initiative by Astellas Pharma EMEA. Please remember to return often to read the news, clinical insights, and essential information from the latest anti-infective congresses.

January 2015 FDX/15/0003/EU

 

Bedwetting CME

This free CME activity covers the best practice management of nocturnal enuresis through three case study-led modules, including a more severe and complex patient scenario. It is intended for Urologists, Paediatricians, Primary Care Providers and General Practitioners looking to improve their understanding and management of bedwetting.

 

Accredited Obesity CME

The EACCME accredited European Obesity Initiative eCME module – Understanding Obesity, is freely accessible to healthcare professionals. Upon successful completion, participants will be awarded 2 European CME credits (ECMECs) and have a broad understanding of the epidemiology, contributory factors and management options for patients with obesity.

 

Type 2 Diabetes accredited CME

‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ is EACCME accredited and awarded 1 European CME credit (ECMEC). There are 3 modules:

  • A Review of Newer Therapies for Type 2 Diabetes in Combination with Insulin; John Wilding (Chair)
  • Identifying and Managing the Psychosocial Aspects of Type 2 Diabetes Mellitus; Richard Holt (Faculty)
  • Potential Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin: Interactive Case Discussion; Bernard Charbonnel (Faculty)
     

Latest News

CHMP recommends approval of Avastin plus chemo in cervical cancer-Roche

02-Mar-2015

The European Union’s Committee for Medicinal Products for Human Use has issued a positive opinion on the use of Avastin (bevacizumab), from Roche, in combination with standard chemotherapy (paclitaxel and cisplatin or, alternatively, paclitaxel ...

Opdivo (nivolumab) filed at FDA for treatment of NSCLC- BMS

01-Mar-2015

Bristol-Myers Squibb announced that the FDA has accepted for filing and review the Biologics Licensing Application (BLA) for Opdivo (nivolumab) for the treatment of patients with advanced squamous non-small cell lung cancer (NSCLC) after prior ...

CHMP recommends Toujeo (insulin glargine [rDNA origin]) for treatment of type 1 and type 2 diabetes-Sanofi

01-Mar-2015

Sanofi has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL), a ...

EU extends approval of Vectibix plus FOLFIRI in wild-type RAS mCRC-Amgen

01-Mar-2015

The committee for medicinal products for human use of the European Medicines Agency has adopted a positive opinion to extend the marketing authorization for Vectibix (panitumumab), from Amgen, to include combination with FOLFIRI (irinotecan-based ...

CHMP recommends approval of Jinarc in ADPKD-Otsuka Pharmaceutical

01-Mar-2015

The Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended Jinarc (tolvaptan), from Otsuka Pharmaceutical, for approval to slow the progression of cyst development and renal insufficiency of autosomal dominant ...

CHMP recommends updated indications for Soliris in PNH-Alexion

01-Mar-2015

The Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion to update the therapeutic indication for Soliris (eculizumab), from Alexion, in the treatment of paroxysmal nocturnal haemoglobinuria ...

CHMP recommends updating indication for Soliris in aHUS-Alexion

01-Mar-2015

The Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion to update the therapeutic indication for Soliris (eculizumab), from Alexion, with additional data on the benefits of long-term ...

Recent Updates

Drugs

Clinical Guidelines

Guidelines on Prostate Cancer

Early and locally advanced breast cancer: Diagnosis and treatment

Medical Journals

How growth due to infant nutrition influences obesity and later disease risk

A comparison of obesity related adipokine concentrations in knee and shoulder osteoarthritis patients

The implications of obesity on pregnancy outcome

High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial

epgonline.org Social